60 related articles for article (PubMed ID: 2123144)
1. Prevention of adult respiratory distress syndrome with plasminogen activator in pigs.
Hardaway RM; Williams CH; Marvasti M; Farias M; Tseng A; Pinon I; Yanez D; Martinez M; Navar J
Crit Care Med; 1990 Dec; 18(12):1413-8. PubMed ID: 2123144
[TBL] [Abstract][Full Text] [Related]
2. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series.
Wang J; Hajizadeh N; Moore EE; McIntyre RC; Moore PK; Veress LA; Yaffe MB; Moore HB; Barrett CD
J Thromb Haemost; 2020 Jul; 18(7):1752-1755. PubMed ID: 32267998
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolytic therapy in patients with COVID-19 and ARDS: protocol for a systematic review and meta-analysis.
Savioli F; Ribeiro Dos Santos L; Duarte ML; Feitosa do Carmo AC; Gois A; Nakano L; Da Silva Ramos FJ; Pastore L; Costa ELV
BMJ Open; 2023 Jan; 13(1):e066623. PubMed ID: 36593003
[TBL] [Abstract][Full Text] [Related]
4. Case series of nebulizing r-tPA for COVID-19 induced acute respiratory distress syndrome.
Amini S; Labbani-Motlagh Z; Aliannejad R; Pourabbas SM; Vasei M
Clin Case Rep; 2022 Sep; 10(9):e6283. PubMed ID: 36093444
[TBL] [Abstract][Full Text] [Related]
5. Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management.
Aslan A; Aslan C; Zolbanin NM; Jafari R
Pneumonia (Nathan); 2021 Dec; 13(1):14. PubMed ID: 34872623
[TBL] [Abstract][Full Text] [Related]
6. A Narrative Review of Existing Options for COVID-19-Specific Treatments.
Yadullahi Mir WA; Siddiqui AH; Valecha G; Patel S; Ayub F; Upadhyay R; Alhajri SA; Gaire S; Shrestha DB
Adv Virol; 2021; 2021():8554192. PubMed ID: 34804163
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications.
Lim MS; Mcrae S
Crit Rev Oncol Hematol; 2021 Dec; 168():103529. PubMed ID: 34800652
[TBL] [Abstract][Full Text] [Related]
8. Acute pulmonary embolism and systemic thrombolysis in the era of COVID-19 global pandemic 2020: a case series of seven patients admitted to a regional hospital in the French epidemic cluster.
Philippe J; Cordeanu EM; Leimbach MB; Greciano S; Younes W
Eur Heart J Case Rep; 2021 Feb; 5(2):ytaa522. PubMed ID: 33594346
[TBL] [Abstract][Full Text] [Related]
9. COVID-19-Associated Hyper-Fibrinolysis: Mechanism and Implementations.
Jacob G; Aharon A; Brenner B
Front Physiol; 2020; 11():596057. PubMed ID: 33391014
[TBL] [Abstract][Full Text] [Related]
10. Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia: JACC Focus Seminar.
Giustino G; Pinney SP; Lala A; Reddy VY; Johnston-Cox HA; Mechanick JI; Halperin JL; Fuster V
J Am Coll Cardiol; 2020 Oct; 76(17):2011-2023. PubMed ID: 33092737
[TBL] [Abstract][Full Text] [Related]
11. The Role of Therapeutic Anticoagulation in COVID-19.
McGovern R; Conway P; Pekrul I; Tujjar O
Case Rep Crit Care; 2020; 2020():8835627. PubMed ID: 32908713
[TBL] [Abstract][Full Text] [Related]
12. Thrombosis in COVID-19.
Hanff TC; Mohareb AM; Giri J; Cohen JB; Chirinos JA
Am J Hematol; 2020 Dec; 95(12):1578-1589. PubMed ID: 32857878
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy for Prevention and Management of Thrombosis in COVID-19.
Hashemi A; Madhavan MV; Bikdeli B
Semin Thromb Hemost; 2020 Oct; 46(7):789-795. PubMed ID: 32820478
[No Abstract] [Full Text] [Related]
14. Management of Thrombotic Complications in COVID-19: An Update.
Hajra A; Mathai SV; Ball S; Bandyopadhyay D; Veyseh M; Chakraborty S; Lavie CJ; Aronow WS
Drugs; 2020 Oct; 80(15):1553-1562. PubMed ID: 32803670
[TBL] [Abstract][Full Text] [Related]
15. Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies.
Allegra A; Innao V; Allegra AG; Musolino C
Ann Hematol; 2020 Sep; 99(9):1953-1965. PubMed ID: 32671455
[TBL] [Abstract][Full Text] [Related]
16. A Systematic Review of Cases of Acute Respiratory Distress Syndrome in the Coronavirus Disease 2019 Pandemic.
Baksh M; Ravat V; Zaidi A; Patel RS
Cureus; 2020 May; 12(5):e8188. PubMed ID: 32566429
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolysis and COVID-19: A plasmin paradox.
Medcalf RL; Keragala CB; Myles PS
J Thromb Haemost; 2020 Sep; 18(9):2118-2122. PubMed ID: 32543119
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolytic therapy for refractory COVID-19 acute respiratory distress syndrome: Scientific rationale and review.
Barrett CD; Moore HB; Moore EE; McIntyre RC; Moore PK; Burke J; Hua F; Apgar J; Talmor DS; Sauaia A; Liptzin DR; Veress LA; Yaffe MB
Res Pract Thromb Haemost; 2020 May; 4(4):524-531. PubMed ID: 32542213
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research.
Bikdeli B; Madhavan MV; Gupta A; Jimenez D; Burton JR; Der Nigoghossian C; Chuich T; Nouri SN; Dreyfus I; Driggin E; Sethi S; Sehgal K; Chatterjee S; Ageno W; Madjid M; Guo Y; Tang LV; Hu Y; Bertoletti L; Giri J; Cushman M; Quéré I; Dimakakos EP; Gibson CM; Lippi G; Favaloro EJ; Fareed J; Tafur AJ; Francese DP; Batra J; Falanga A; Clerkin KJ; Uriel N; Kirtane A; McLintock C; Hunt BJ; Spyropoulos AC; Barnes GD; Eikelboom JW; Weinberg I; Schulman S; Carrier M; Piazza G; Beckman JA; Leon MB; Stone GW; Rosenkranz S; Goldhaber SZ; Parikh SA; Monreal M; Krumholz HM; Konstantinides SV; Weitz JI; Lip GYH;
Thromb Haemost; 2020 Jul; 120(7):1004-1024. PubMed ID: 32473596
[TBL] [Abstract][Full Text] [Related]
20. Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae.
Kwaan HC
Semin Thromb Hemost; 2020 Oct; 46(7):841-844. PubMed ID: 32386428
[No Abstract] [Full Text] [Related]
[Next] [New Search]
